List of works - Katia Mazzocco

A multilocus technique for risk evaluation of patients with neuroblastoma

scientific article published on February 2011

Biological and clinical role of p73 in neuroblastoma

scientific article

Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins

scientific article

Concomitant DDX1 and MYCN gain in neuroblastoma

scientific article published on 03 July 2007

Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.

scientific article published on 13 September 2013

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

scientific article published on 12 April 2017

Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization

scientific article published on 01 January 2004

Evidence of apoptosis in neuroblastoma at onset and relapse. An analysis of a large series of tumors

scientific article published on 01 January 1997

Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients

scientific article published on 01 March 2002

Gene expression and protein localisation of calcyclin, a calcium-binding protein of the S-100 family in fresh neuroblastomas

scientific article published on 01 January 1995

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group

scientific article published on 29 April 2015

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

scientific article published in November 2005

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

scientific article published on 5 March 2018

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study

scientific article published on 14 May 2018

Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma

scientific article published on 01 May 2003

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization

scientific article published on 01 August 2007

Identification of an AP-1-like sequence in the promoter region of calcyclin, a S-100-like gene. Enhancement of binding during retinoic acid-induced neuroblastoma cell differentiation.

scientific article

Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma

scientific article published on 01 October 2008

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

scientific article published on 4 November 2014

Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome

scientific article published on 01 August 1998

Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.

scientific article

Loss of heterozygosity for chromosome 1p in familial neuroblastoma

scientific article published on 01 October 1997

MDM2SNP309 genotype influences survival of metastatic but not of localized neuroblastoma

scientific article published on 01 October 2009

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children

scientific article published on 01 January 1997

Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases

scientific article published on 23 April 2003

Neuroblastoma in adolescents

scientific article published on 01 March 2006

Neuroblastoma in the adult: the Italian experience with 21 patients

scientific article published on 01 November 2014

Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development

scientific article published on 01 March 1999

Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients

scientific article

Peculiar allelotype associated with susceptibility to neuroblastoma

scientific article published in September 1996

Piloting the European Unified Patient Identity Management (EUPID) Concept to Facilitate Secondary Use of Neuroblastoma Data from Clinical Trials and Biobanking.

scientific article

Quality assessment of genetic markers used for therapy stratification.

scientific article published in June 2003

Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system

scientific article published on 01 November 1999

Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients

scientific article published in October 1997

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

scientific article published on 10 November 2011

Simultaneous tumors: acute myeloid leukemia infiltrating mediastinal ganglioneuroblastoma

scientific article published on 01 February 2011

Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease

scientific article published on 17 September 2018

Stage-independent expression and genetic analysis of tp73 in neuroblastoma.

scientific article

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis

scientific article published in July 2009

Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors

scientific article published on 01 May 2002

[Oncogenes and suppressor genes in the genesis and progression of solid tumors in children]

scientific article

[The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)]

scientific article published on 01 May 1994

List of works by Katia Mazzocco

A multilocus technique for risk evaluation of patients with neuroblastoma

Biological and clinical role of p73 in neuroblastoma

Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins

Concomitant DDX1 and MYCN gain in neuroblastoma

Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization

Evidence of apoptosis in neuroblastoma at onset and relapse. An analysis of a large series of tumors

Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients

Gene expression and protein localisation of calcyclin, a calcium-binding protein of the S-100 family in fresh neuroblastomas

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study

Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization

Identification of an AP-1-like sequence in the promoter region of calcyclin, a S-100-like gene. Enhancement of binding during retinoic acid-induced neuroblastoma cell differentiation.

Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome

Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.

Loss of heterozygosity for chromosome 1p in familial neuroblastoma

MDM2SNP309 genotype influences survival of metastatic but not of localized neuroblastoma

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children

Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases

Neuroblastoma in adolescents

Neuroblastoma in the adult: the Italian experience with 21 patients

Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development

Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients

Peculiar allelotype associated with susceptibility to neuroblastoma

Piloting the European Unified Patient Identity Management (EUPID) Concept to Facilitate Secondary Use of Neuroblastoma Data from Clinical Trials and Biobanking.

Quality assessment of genetic markers used for therapy stratification.

Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system

Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Simultaneous tumors: acute myeloid leukemia infiltrating mediastinal ganglioneuroblastoma

Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease

Stage-independent expression and genetic analysis of tp73 in neuroblastoma.

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis

Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors

[Oncogenes and suppressor genes in the genesis and progression of solid tumors in children]

[The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)]